RxDoctor Payments Data

Alan Hilibrand, MD

Orthopaedic Surgery of the Spine · Bensalem, PANPI 1609820315

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,351,181 of the $1,352,407 with a category attached, or 99.9%. 7 manufacturers reported payments, led by Zimmer Biomet at 56.8% of the total. Reporting peaked in 2019 at $425,608 and has fallen 78.1% since, to $93,017 in 2025. Among orthopaedic surgery of the spine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,352,407in general payments, 2019–2025

Across 69 payments — averaging $19,600 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$769K
  • Zimvie Inc.$353K
  • Highridge Medical LLC$184K
  • CTL Medical Corporation$45K
  • Orthofix Medical, Inc.$885
  • Kuros Biosciences USA, Inc$285
  • plus $57 from 1 others

What the payments were for

  • Royalty or licence$1,351,181100%
  • Travel & lodging$6680%
  • Food & beverage$5590%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,352,407 in reported general payments places this provider in the 95th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$439,804
Medicare patients
611
Services billed
2,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin107$596
Celecoxib14$189
Methylprednisolone22$120
Tizanidine Hcl11$63

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Bensalem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →